Phase I and expanded access experience of LOXO-195 (BAY 2731954), a selective next-generation TRK inhibitor (TRKi) Meeting Abstract
| Authors: | Hyman, D.; Kummar, S.; Farago, A.; Geoerger, B.; Mau-Sorensen, M.; Taylor, M.; Garralda, E.; Nagasubramanian, R.; Natheson, M.; Song, L.; Capra, M.; Jorgensen, M.; Ho, A.; Shukla, N.; Smith, S.; Huang, X.; Tuch, B.; Ku, N.; Laetsch, T. W.; Drilon, A.; Hong, D. |
| Abstract Title: | Phase I and expanded access experience of LOXO-195 (BAY 2731954), a selective next-generation TRK inhibitor (TRKi) |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129900113 |
| DOI: | 10.1158/1538-7445.Am2019-ct127 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT127 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
